Concepedia

Jean‐François Cajot

JC

Statistics

Publications

11

Citations

655

H-Index

11

Active since

1986

Affiliations

Swiss Group For Clinical Cancer Research(Current)

University of Lausanne

Jean‐François Cajot is an author at Swiss Group For Clinical Cancer Research specializing in medicine, cell biology, and tumor biology.

Top concepts

Publications per year

1986–2003

11

Publications

11

Plasminogen-activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells.

Jean‐François Cajot, J. Bamat, Gabriela E. Bergonzelli et al. · Proceedings of the National Academy of Sciences · 1990 · 133 citations · Full text

, , +19

Differential display cloning identifies motility-related protein (MRP1/CD9) as highly expressed in primary compared to metastatic human colon carcinoma cells.

Jean‐François Cajot, Isabelle Sordat, Timothée Silvestre et al. · PubMed · 1997 · 109 citations

, , +15

Mouse L cells expressing human prourokinase-type plasminogen activator: effects on extracellular matrix degradation and invasion.

Jean‐François Cajot, Wolf‐Dieter Schleuning, Robert L. Medcalf et al. · The Journal of Cell Biology · 1989 · 98 citations · Full text

, , +19

Plasminogen activators, plasminogen activator inhibitors and procoagulant analyzed in twenty human tumor cell lines

Jean‐François Cajot, Egbert K. O. Kruithof, Wolf‐Dieter Schleuning et al. · International Journal of Cancer · 1986 · 84 citations

The role of the urokinase receptor in extracellular matrix degradation by ht29 human colon carcinoma cells

Lars S. Reiter, Egbert K. O. Kruithof, Jean‐François Cajot et al. · International Journal of Cancer · 1993 · 49 citations

1–5 of 11